{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:16Z","timestamp":1786982116008,"version":"build-2736575974"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11882-021-01001-2","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T19:18:05Z","timestamp":1616699885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Paget\u2019s Disease of Bone: Osteoimmunology and Osteoclast Pathology"],"prefix":"10.1007","volume":"21","author":[{"given":"Emily M.","family":"Rabjohns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katlyn","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arin","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Cuellar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi R.","family":"Rampersad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4067-5363","authenticated-orcid":false,"given":"Teresa K.","family":"Tarrant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,25]]},"reference":[{"issue":"3","key":"1001_CR1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/0967772014533055","volume":"26","author":"N Toodayan","year":"2018","unstructured":"Toodayan N. The Paget bicentenary: an Australian perspective. J Med Biogr. 2018;26(3):164\u201371.","journal-title":"J Med Biogr"},{"issue":"1","key":"1001_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/1117-6806.127098","volume":"20","author":"R Sabharwal","year":"2014","unstructured":"Sabharwal R, Gupta S, Sepolia S, Panigrahi R, Mohanty S, Subudhi SK, et al. An insight in to Paget\u2019s disease of bone. Niger J Surg. 2014;20(1):9\u201315.","journal-title":"Niger J Surg"},{"key":"1001_CR3","unstructured":"Singer FR. Paget\u2019s Disease of Bone. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, et al., editors. Endotext. South Dartmouth (MA) 2000."},{"issue":"9","key":"1001_CR4","doi-asserted-by":"publisher","first-page":"dmm035576","DOI":"10.1242\/dmm.035576","volume":"11","author":"A Daroszewska","year":"2018","unstructured":"Daroszewska A, Rose L, Sarsam N, Charlesworth G, Prior A, Rose K, et al. Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62(P394L) mouse model of Paget\u2019s disease. Dis Model Mech. 2018;11(9):dmm035576 Comment: primary research of a p62 mutation mouse model of Paget\u2019s disease.","journal-title":"Dis Model Mech"},{"issue":"6172","key":"1001_CR5","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1136\/bmj.1.6172.1217-e","volume":"1","author":"TM Gasper","year":"1979","unstructured":"Gasper TM. Paget\u2019s disease in a treadle machine operator. Br Med J. 1979;1(6172):1217\u20138.","journal-title":"Br Med J"},{"issue":"6168","key":"1001_CR6","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1136\/bmj.1.6168.931","volume":"1","author":"LR Solomon","year":"1979","unstructured":"Solomon LR. Billiard-player\u2019s fingers: an unusual case of Paget\u2019s disease of bone. Br Med J. 1979;1(6168):931.","journal-title":"Br Med J"},{"issue":"8","key":"1001_CR7","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/jbmr.64","volume":"25","author":"S Mays","year":"2010","unstructured":"Mays S. Archaeological skeletons support a northwest European origin for Paget\u2019s disease of bone. J Bone Miner Res. 2010;25(8):1839\u201341.","journal-title":"J Bone Miner Res"},{"key":"1001_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ijpp.2018.08.005","volume":"24","author":"MJ Kesterke","year":"2019","unstructured":"Kesterke MJ, Judd MA. A microscopic evaluation of Paget\u2019s disease of bone from a Byzantine monastic crypt in Jordan. Int J Paleopathol. 2019;24:293\u20138.","journal-title":"Int J Paleopathol"},{"issue":"6","key":"1001_CR9","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1359\/jbmr.2002.17.6.1127","volume":"17","author":"J Rogers","year":"2002","unstructured":"Rogers J, Jeffrey DR, Watt I. Paget\u2019s disease in an archeological population. J Bone Miner Res. 2002;17(6):1127\u201334.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1001_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1359\/JBMR.040201","volume":"19","author":"HA Waldron","year":"2004","unstructured":"Waldron HA. Recalculation of secular trends in Paget\u2019s disease. J Bone Miner Res. 2004;19(3):523.","journal-title":"J Bone Miner Res"},{"issue":"8","key":"1001_CR11","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1359\/JBMR.050505","volume":"20","author":"CM Pusch","year":"2005","unstructured":"Pusch CM, Czarnetzki A. Archaeology and prevalence of Paget\u2019s disease. J Bone Miner Res. 2005;20(8):1484 author reply 5.","journal-title":"J Bone Miner Res"},{"issue":"21","key":"1001_CR12","doi-asserted-by":"publisher","first-page":"10463","DOI":"10.1073\/pnas.1820556116","volume":"116","author":"B Shaw","year":"2019","unstructured":"Shaw B, Burrell CL, Green D, Navarro-Martinez A, Scott D, Daroszewska A, et al. Molecular insights into an ancient form of Paget\u2019s disease of bone. Proc Natl Acad Sci U S A. 2019;116(21):10463\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1001_CR13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1359\/jbmr.080215","volume":"23","author":"RA Wermers","year":"2008","unstructured":"Wermers RA, Tiegs RD, Atkinson EJ, Achenbach SJ, Melton LJ 3rd. Morbidity and mortality associated with Paget\u2019s disease of bone: a population-based study. J Bone Miner Res. 2008;23(6):819\u201325.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1001_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/1759720X09351779","volume":"1","author":"JL Shaker","year":"2009","unstructured":"Shaker JL. Paget\u2019s disease of bone: a review of epidemiology, pathophysiology and management. Ther Adv Musculoskelet Dis. 2009;1(2):107\u201325.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"5","key":"1001_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00223-014-9904-1","volume":"95","author":"A Tan","year":"2014","unstructured":"Tan A, Ralston SH. Clinical presentation of Paget\u2019s disease: evaluation of a contemporary cohort and systematic review. Calcif Tissue Int. 2014;95(5):385\u201392.","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"1001_CR16","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/ard.43.6.769","volume":"43","author":"J Winfield","year":"1984","unstructured":"Winfield J, Stamp TC. Bone and joint symptoms in Paget\u2019s disease. Ann Rheum Dis. 1984;43(6):769\u201373.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1001_CR17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/jbmr.5650100318","volume":"10","author":"L Alvarez","year":"1995","unstructured":"Alvarez L, Guanabens N, Peris P, Monegal A, Bedini JL, Deulofeu R, et al. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget\u2019s disease. J Bone Miner Res. 1995;10(3):458\u201365.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1001_CR18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00223-019-00522-3","volume":"104","author":"L Gennari","year":"2019","unstructured":"Gennari L, Rendina D, Falchetti A, Merlotti D. Paget\u2019s disease of bone. Calcif Tissue Int. 2019;104(5):483\u2013500.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"1001_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/jbmr.3657","volume":"34","author":"SH Ralston","year":"2019","unstructured":"Ralston SH, Corral-Gudino L, Cooper C, Francis RM, Fraser WD, Gennari L, et al. Diagnosis and management of paget\u2019s disease of bone in adults: a clinical guideline. J Bone Miner Res. 2019;34(4):579\u2013604.","journal-title":"J Bone Miner Res"},{"issue":"7","key":"1001_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3949\/ccjm.80a.12142","volume":"80","author":"M Seton","year":"2013","unstructured":"Seton M. Paget disease of bone: diagnosis and drug therapy. Cleve Clin J Med. 2013;80(7):452\u201362.","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"1001_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1359\/jbmr.080907","volume":"24","author":"S Seitz","year":"2009","unstructured":"Seitz S, Priemel M, Zustin J, Beil FT, Semler J, Minne H, et al. Paget\u2019s disease of bone: histologic analysis of 754 patients. J Bone Miner Res. 2009;24(1):62\u20139.","journal-title":"J Bone Miner Res"},{"issue":"Suppl","key":"1001_CR22","first-page":"283","volume":"22","author":"A Rebel","year":"1977","unstructured":"Rebel A, Malkani K, Basle M, Bregeon C. Is Paget\u2019s disease of bone a viral infection? Calcif Tissue Res. 1977;22(Suppl):283\u20136.","journal-title":"Calcif Tissue Res"},{"issue":"4261","key":"1001_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1126\/science.959849","volume":"194","author":"BG Mills","year":"1976","unstructured":"Mills BG, Singer FR. Nuclear inclusions in Paget\u2019s disease of bone. Science. 1976;194(4261):201\u20132.","journal-title":"Science."},{"issue":"1-2","key":"1001_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s10354-016-0496-4","volume":"167","author":"E Nebot Valenzuela","year":"2017","unstructured":"Nebot Valenzuela E, Pietschmann P. Epidemiology and pathology of Paget\u2019s disease of bone - a review. Wien Med Wochenschr. 2017;167(1-2):2\u20138.","journal-title":"Wien Med Wochenschr"},{"key":"1001_CR25","doi-asserted-by":"crossref","unstructured":"Reid IR. Recent advances in understanding and managing Paget\u2019s disease. F1000Res. 2019;8.","DOI":"10.12688\/f1000research.19676.1"},{"key":"1001_CR26","unstructured":"Stanislavsky A Polyostotic Paget Disease 2011 [Available from: https:\/\/radiopaedia.org\/cases\/polyostotic-paget-disease?lang=us."},{"issue":"11","key":"1001_CR27","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrendo.2015.138","volume":"11","author":"FR Singer","year":"2015","unstructured":"Singer FR. Paget\u2019s disease of bone-genetic and environmental factors. Nat Rev Endocrinol. 2015;11(11):662\u201371.","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"1001_CR28","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1210\/jc.2014-2910","volume":"99","author":"FR Singer","year":"2014","unstructured":"Singer FR, Bone HG 3rd, Hosking DJ, Lyles KW, Murad MH, Reid IR, et al. Paget\u2019s disease of bone: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(12):4408\u201322.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"1001_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10354-016-0517-3","volume":"167","author":"N Winn","year":"2017","unstructured":"Winn N, Lalam R, Cassar-Pullicino V. Imaging of Paget\u2019s disease of bone. Wien Med Wochenschr. 2017;167(1-2):9\u201317.","journal-title":"Wien Med Wochenschr"},{"issue":"4","key":"1001_CR30","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/00005537-200404000-00002","volume":"114","author":"EM Monsell","year":"2004","unstructured":"Monsell EM. The mechanism of hearing loss in Paget\u2019s disease of bone. Laryngoscope. 2004;114(4):598\u2013606.","journal-title":"Laryngoscope."},{"issue":"6","key":"1001_CR31","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1359\/jbmr.1997.12.6.929","volume":"12","author":"KW Lyles","year":"1997","unstructured":"Lyles KW, Gold DT, Newton RA, Parekh S, Shipp KM, Pieper CF, et al. Peyronie\u2019s disease is associated with Paget\u2019s disease of bone. J Bone Miner Res. 1997;12(6):929\u201334.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"1001_CR32","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1056\/NEJMoa044241","volume":"353","author":"IR Reid","year":"2005","unstructured":"Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, et al. Comparison of a single infusion of zoledronic acid with risedronate for Paget\u2019s disease. N Engl J Med. 2005;353(9):898\u2013908.","journal-title":"N Engl J Med"},{"issue":"5","key":"1001_CR33","first-page":"913","volume":"3","author":"M Seton","year":"2007","unstructured":"Seton M, Krane SM. Use of zoledronic acid in the treatment of Paget\u2019s disease. Ther Clin Risk Manag. 2007;3(5):913\u20138.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"1001_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1359\/jbmr.061001","volume":"22","author":"D Hosking","year":"2007","unstructured":"Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, et al. Long-term control of bone turnover in Paget\u2019s disease with zoledronic acid and risedronate. J Bone Miner Res. 2007;22(1):142\u20138.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1001_CR35","first-page":"961","volume":"81","author":"E Siris","year":"1996","unstructured":"Siris E, Weinstein RS, Altman R, Conte JM, Favus M, Lombardi A, et al. Comparative study of alendronate versus etidronate for the treatment of Paget\u2019s disease of bone. J Clin Endocrinol Metab. 1996;81(3):961\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1001_CR36","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.bone.2003.12.011","volume":"34","author":"JP Walsh","year":"2004","unstructured":"Walsh JP, Ward LC, Stewart GO, Will RK, Criddle RA, Prince RL, et al. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget\u2019s disease of bone. Bone. 2004;34(4):747\u201354.","journal-title":"Bone."},{"issue":"5","key":"1001_CR37","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0002-9343(99)00062-5","volume":"106","author":"PD Miller","year":"1999","unstructured":"Miller PD, Brown JP, Siris ES, Hoseyni MS, Axelrod DW, Bekker PJ. A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget\u2019s disease of bone. Paget\u2019s Risedronate\/Etidronate Study Group. Am J Med. 1999;106(5):513\u201320.","journal-title":"Am J Med"},{"issue":"3","key":"1001_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00223-004-0103-3","volume":"75","author":"D Rendina","year":"2004","unstructured":"Rendina D, Mossetti G, Viceconti R, Sorrentino M, Nunziata V. Risedronate and pamidronate treatment in the clinical management of patients with severe Paget\u2019s disease of bone and acquired resistance to bisphosphonates. Calcif Tissue Int. 2004;75(3):189\u201396.","journal-title":"Calcif Tissue Int"},{"key":"1001_CR39","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2147\/TCRM.S58367","volume":"10","author":"WZ Wat","year":"2014","unstructured":"Wat WZ. Current perspectives on bisphosphonate treatment in Paget\u2019s disease of bone. Ther Clin Risk Manag. 2014;10:977\u201383.","journal-title":"Ther Clin Risk Manag"},{"issue":"22","key":"1001_CR40","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1093\/hmg\/11.22.2735","volume":"11","author":"LJ Hocking","year":"2002","unstructured":"Hocking LJ, Lucas GJ, Daroszewska A, Mangion J, Olavesen M, Cundy T, et al. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget\u2019s disease. Hum Mol Genet. 2002;11(22):2735\u20139.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"1001_CR41","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/jbmr.438","volume":"26","author":"IR Reid","year":"2011","unstructured":"Reid IR, Lyles K, Su G, Brown JP, Walsh JP, del Pino-Montes J, et al. A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years. J Bone Miner Res. 2011;26(9):2261\u201370.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1001_CR42","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/jbmr.3029","volume":"32","author":"T Cundy","year":"2017","unstructured":"Cundy T, Maslowski K, Grey A, Reid IR. Durability of response to Zoledronate treatment and competing mortality in Paget\u2019s disease of bone. J Bone Miner Res. 2017;32(4):753\u20136.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1001_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1359\/jbmr.090709","volume":"25","author":"AL Langston","year":"2010","unstructured":"Langston AL, Campbell MK, Fraser WD, MacLennan GS, Selby PL, Ralston SH, et al. Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget\u2019s disease of bone. J Bone Miner Res. 2010;25(1):20\u201331.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1001_CR44","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s00223-016-0150-6","volume":"99","author":"IR Reid","year":"2016","unstructured":"Reid IR, Sharma S, Kalluru R, Eagleton C. Treatment of Paget\u2019s disease of bone with denosumab: case report and literature review. Calcif Tissue Int. 2016;99(3):322\u20135.","journal-title":"Calcif Tissue Int"},{"issue":"10","key":"1001_CR45","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/art.1780231009","volume":"23","author":"HC Barry","year":"1980","unstructured":"Barry HC. Orthopedic aspects of Paget\u2019s disease of bone. Arthritis Rheum. 1980;23(10):1128\u201330.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1001_CR46","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/00005131-198912000-00011","volume":"3","author":"S Bidner","year":"1989","unstructured":"Bidner S, Finnegan M. Femoral fractures in Paget\u2019s disease. J Orthop Trauma. 1989;3(4):317\u201322.","journal-title":"J Orthop Trauma"},{"issue":"4","key":"1001_CR47","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.bone.2006.04.032","volume":"39","author":"HE Whitson","year":"2006","unstructured":"Whitson HE, Lobaugh B, Lyles KW. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget\u2019s disease of bone. Bone. 2006;39(4):954\u20138.","journal-title":"Bone."},{"issue":"Suppl 2","key":"1001_CR48","doi-asserted-by":"publisher","first-page":"P75","DOI":"10.1359\/jbmr.06s214","volume":"21","author":"J Parvizi","year":"2006","unstructured":"Parvizi J, Klein GR, Sim FH. Surgical management of Paget\u2019s disease of bone. J Bone Miner Res. 2006;21(Suppl 2):P75\u201382.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1001_CR49","first-page":"43","volume":"87","author":"P Calderoni","year":"2002","unstructured":"Calderoni P, Ferruzzi A, Andreoli I, Gualtieri G. Hip arthroplasty in coxarthrosis secondary to Paget\u2019s disease. Chir Organi Mov. 2002;87(1):43\u20138.","journal-title":"Chir Organi Mov"},{"issue":"1","key":"1001_CR50","first-page":"69","volume":"54","author":"R Wootton","year":"1978","unstructured":"Wootton R, Reeve J, Spellacy E, Tellez-Yudilevich M. Skeletal blood flow in Paget\u2019s disease of bone and its response to calcitonin therapy. Clin Sci Mol Med. 1978;54(1):69\u201374.","journal-title":"Clin Sci Mol Med"},{"key":"1001_CR51","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1749-6632.2009.05214.x","volume":"1192","author":"GD Roodman","year":"2010","unstructured":"Roodman GD. Insights into the pathogenesis of Paget\u2019s disease. Ann N Y Acad Sci. 2010;1192:176\u201380.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1001_CR52","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jbspin.2018.12.007","volume":"86","author":"MS Numan","year":"2019","unstructured":"Numan MS, Jean S, Dessay M, Gagnon E, Amiable N, Brown JP, et al. Gene-environment interactions in Paget\u2019s disease of bone. Joint Bone Spine. 2019;86(3):373\u201380.","journal-title":"Joint Bone Spine"},{"issue":"955","key":"1001_CR53","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1259\/bjr\/84718521","volume":"80","author":"MJ Haddaway","year":"2007","unstructured":"Haddaway MJ, Davie MW, McCall IW, Howdle S. Effect of age and gender on the number and distribution of sites in Paget\u2019s disease of bone. Br J Radiol. 2007;80(955):532\u20136.","journal-title":"Br J Radiol"},{"issue":"7","key":"1001_CR54","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1359\/jbmr.070333","volume":"22","author":"G Beyens","year":"2007","unstructured":"Beyens G, Daroszewska A, de Freitas F, Fransen E, Vanhoenacker F, Verbruggen L, et al. Identification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Paget\u2019s disease of bone. J Bone Miner Res. 2007;22(7):1062\u201371.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1001_CR55","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41418-019-0341-6","volume":"27","author":"SW Wong","year":"2020","unstructured":"Wong SW, Huang BW, Hu X, Ho Kim E, Kolb JP, Padilla RJ, et al. Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget\u2019s disease. Cell Death Differ. 2020;27(1):71\u201384 Comment: primary research of an optineurin-deficient mouse model of Paget\u2019s disease.","journal-title":"Cell Death Differ"},{"issue":"4","key":"1001_CR56","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/jbmr.5650100421","volume":"10","author":"AA Morales-Piga","year":"1995","unstructured":"Morales-Piga AA, Rey-Rey JS, Corres-Gonzalez J, Garcia-Sagredo JM, Lopez-Abente G. Frequency and characteristics of familial aggregation of Paget\u2019s disease of bone. J Bone Miner Res. 1995;10(4):663\u201370.","journal-title":"J Bone Miner Res"},{"issue":"8","key":"1001_CR57","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1359\/jbmr.2003.18.8.1519","volume":"18","author":"M Seton","year":"2003","unstructured":"Seton M, Choi HK, Hansen MF, Sebaldt RJ, Cooper C. Analysis of environmental factors in familial versus sporadic Paget\u2019s disease of bone--the New England Registry for Paget\u2019s Disease of Bone. J Bone Miner Res. 2003;18(8):1519\u201324.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1001_CR58","first-page":"e22","volume":"15","author":"M Merashli","year":"2015","unstructured":"Merashli M, Jawad A. Paget\u2019s Disease of Bone among Various Ethnic Groups. Sultan Qaboos Univ Med J. 2015;15(1):e22\u20136.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"1001_CR59","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.metabol.2017.06.010","volume":"80","author":"T Cundy","year":"2018","unstructured":"Cundy T. Paget\u2019s disease of bone. Metabolism. 2018;80:5\u201314 Comment: recent comprehensive review of Paget\u2019s Disease of Bone.","journal-title":"Metabolism"},{"issue":"8","key":"1001_CR60","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1359\/JBMR.050322","volume":"20","author":"D Merlotti","year":"2005","unstructured":"Merlotti D, Gennari L, Galli B, Martini G, Calabro A, De Paola V, et al. Characteristics and familial aggregation of Paget\u2019s disease of bone in Italy. J Bone Miner Res. 2005;20(8):1356\u201364.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"1001_CR61","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jbspin.2016.11.010","volume":"84","author":"MC Audet","year":"2017","unstructured":"Audet MC, Jean S, Beaudoin C, Guay-Belanger S, Dumont J, Brown JP, et al. Environmental factors associated with familial or non-familial forms of Paget\u2019s disease of bone. Joint Bone Spine. 2017;84(6):719\u201323.","journal-title":"Joint Bone Spine"},{"issue":"4","key":"1001_CR62","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jbspin.2011.07.005","volume":"79","author":"L Michou","year":"2012","unstructured":"Michou L, Collet C, Morissette J, Audran M, Thomas T, Gagnon E, et al. Epidemiogenetic study of French families with Paget\u2019s disease of bone. Joint Bone Spine. 2012;79(4):393\u20138.","journal-title":"Joint Bone Spine"},{"issue":"4","key":"1001_CR63","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/0049-0172(94)90037-X","volume":"23","author":"ES Siris","year":"1994","unstructured":"Siris ES. Epidemiological aspects of Paget\u2019s disease: family history and relationship to other medical conditions. Semin Arthritis Rheum. 1994;23(4):222\u20135.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"1001_CR64","first-page":"226","volume":"28","author":"DJ Barker","year":"1974","unstructured":"Barker DJ, Gardner MJ. Distribution of Paget\u2019s disease in England, Wales and Scotland and a possible relationship with vitamin D deficiency in childhood. Br J Prev Soc Med. 1974;28(4):226\u201332.","journal-title":"Br J Prev Soc Med"},{"issue":"3","key":"1001_CR65","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S8756-3282(02)00833-5","volume":"31","author":"JH Lever","year":"2002","unstructured":"Lever JH. Paget\u2019s disease of bone in Lancashire and arsenic pesticide in cotton mill wastewater: a speculative hypothesis. Bone. 2002;31(3):434\u20136.","journal-title":"Bone."},{"issue":"3","key":"1001_CR66","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00001648-199705000-00004","volume":"8","author":"G Lopez-Abente","year":"1997","unstructured":"Lopez-Abente G, Morales-Piga A, Elena-Ibanez A, Rey-Rey JS, Corres-Gonzalez J. Cattle, pets, and Paget\u2019s disease of bone. Epidemiology. 1997;8(3):247\u201351.","journal-title":"Epidemiology."},{"issue":"2","key":"1001_CR67","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00223-012-9599-0","volume":"91","author":"SH Ralston","year":"2012","unstructured":"Ralston SH, Layfield R. Pathogenesis of Paget disease of bone. Calcif Tissue Int. 2012;91(2):97\u2013113.","journal-title":"Calcif Tissue Int"},{"issue":"Suppl 2","key":"1001_CR68","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/jbmr.5650140207","volume":"14","author":"FR Singer","year":"1999","unstructured":"Singer FR. Update on the viral etiology of Paget\u2019s disease of bone. J Bone Miner Res. 1999;14(Suppl 2):29\u201333.","journal-title":"J Bone Miner Res"},{"key":"1001_CR69","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.0105-2896.2005.00323.x","volume":"208","author":"LA Ehrlich","year":"2005","unstructured":"Ehrlich LA, Roodman GD. The role of immune cells and inflammatory cytokines in Paget\u2019s disease and multiple myeloma. Immunol Rev. 2005;208:252\u201366.","journal-title":"Immunol Rev"},{"issue":"4","key":"1001_CR70","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1210\/jc.2007-1978","volume":"93","author":"BG Matthews","year":"2008","unstructured":"Matthews BG, Afzal MA, Minor PD, Bava U, Callon KE, Pitto RP, et al. Failure to detect measles virus ribonucleic acid in bone cells from patients with Paget\u2019s disease. J Clin Endocrinol Metab. 2008;93(4):1398\u2013401.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1001_CR71","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00223-017-0265-4","volume":"101","author":"MR Visconti","year":"2017","unstructured":"Visconti MR, Usategui-Martin R, Ralston SH. Antibody response to Paramyxoviruses in Paget\u2019s disease of bone. Calcif Tissue Int. 2017;101(2):141\u20137.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"1001_CR72","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1359\/jbmr.070103","volume":"22","author":"SH Ralston","year":"2007","unstructured":"Ralston SH, Afzal MA, Helfrich MH, Fraser WD, Gallagher JA, Mee A, et al. Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget\u2019s disease of bone. J Bone Miner Res. 2007;22(4):569\u201377.","journal-title":"J Bone Miner Res"},{"issue":"12","key":"1001_CR73","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1359\/jbmr.2000.15.12.2315","volume":"15","author":"MH Helfrich","year":"2000","unstructured":"Helfrich MH, Hobson RP, Grabowski PS, Zurbriggen A, Cosby SL, Dickson GR, et al. A negative search for a paramyxoviral etiology of Paget\u2019s disease of bone: molecular, immunological, and ultrastructural studies in UK patients. J Bone Miner Res. 2000;15(12):2315\u201329.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1001_CR74","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jbmr.5650090103","volume":"9","author":"MA Birch","year":"1994","unstructured":"Birch MA, Taylor W, Fraser WD, Ralston SH, Hart CA, Gallagher JA. Absence of paramyxovirus RNA in cultures of pagetic bone cells and in pagetic bone. J Bone Miner Res. 1994;9(1):11\u20136.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1001_CR75","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1172\/JCI24281","volume":"115","author":"GD Roodman","year":"2005","unstructured":"Roodman GD, Windle JJ. Paget disease of bone. J Clin Invest. 2005;115(2):200\u20138.","journal-title":"J Clin Invest"},{"issue":"10","key":"1001_CR76","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","volume":"19","author":"M Tsukasaki","year":"2019","unstructured":"Tsukasaki M, Takayanagi H. Osteoimmunology: evolving concepts in bone-immune interactions in health and disease. Nat Rev Immunol. 2019;19(10):626\u201342 Comment: recent review of osteoimmunology.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"1001_CR77","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1182\/blood-2006-07-037994","volume":"109","author":"Y Li","year":"2007","unstructured":"Li Y, Toraldo G, Li A, Yang X, Zhang H, Qian WP, et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood. 2007;109(9):3839\u201348.","journal-title":"Blood."},{"issue":"33","key":"1001_CR78","doi-asserted-by":"publisher","first-page":"25103","DOI":"10.1074\/jbc.R109.041087","volume":"285","author":"LJ Raggatt","year":"2010","unstructured":"Raggatt LJ, Partridge NC. Cellular and molecular mechanisms of bone remodeling. J Biol Chem. 2010;285(33):25103\u20138.","journal-title":"J Biol Chem"},{"issue":"1","key":"1001_CR79","doi-asserted-by":"publisher","DOI":"10.4110\/in.2018.18.e8","volume":"18","author":"DS Amarasekara","year":"2018","unstructured":"Amarasekara DS, Yun H, Kim S, Lee N, Kim H, Rho J. Regulation of osteoclast differentiation by cytokine networks. Immune Netw. 2018;18(1):e8.","journal-title":"Immune Netw"},{"issue":"6","key":"1001_CR80","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nm1417","volume":"12","author":"O Kollet","year":"2006","unstructured":"Kollet O, Dar A, Shivtiel S, Kalinkovich A, Lapid K, Sztainberg Y, et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med. 2006;12(6):657\u201364.","journal-title":"Nat Med"},{"issue":"4","key":"1001_CR81","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1152\/physrev.00036.2016","volume":"97","author":"K Okamoto","year":"2017","unstructured":"Okamoto K, Nakashima T, Shinohara M, Negishi-Koga T, Komatsu N, Terashima A, et al. Osteoimmunology: the conceptual framework unifying the immune and skeletal systems. Physiol Rev. 2017;97(4):1295\u2013349 Comment: recent reivew of osteoimmunology.","journal-title":"Physiol Rev"},{"issue":"1","key":"1001_CR82","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nri3132","volume":"12","author":"FE Mercier","year":"2011","unstructured":"Mercier FE, Ragu C, Scadden DT. The bone marrow at the crossroads of blood and immunity. Nat Rev Immunol. 2011;12(1):49\u201360.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"1001_CR83","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s11882-013-0402-8","volume":"14","author":"JM Brozowski","year":"2014","unstructured":"Brozowski JM, Billard MJ, Tarrant TK. Targeting the molecular and cellular interactions of the bone marrow niche in immunologic disease. Curr Allergy Asthma Rep. 2014;14(2):402 Comment: review of the bone marrow niche components.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1001_CR84","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.3389\/fimmu.2019.01408","volume":"10","author":"MB Madel","year":"2019","unstructured":"Madel MB, Ibanez L, Wakkach A, de Vries TJ, Teti A, Apparailly F, et al. Immune Function and Diversity of Osteoclasts in Normal and Pathological Conditions. Front Immunol. 2019;10:1408 Comment: recent review on osteoclast physiology and roles in immunology.","journal-title":"Front Immunol"},{"issue":"5","key":"1001_CR85","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00223-019-00520-5","volume":"104","author":"SH Ralston","year":"2019","unstructured":"Ralston SH, Taylor JP. Rare Inherited forms of Paget\u2019s Disease and Related Syndromes. Calcif Tissue Int. 2019;104(5):501\u201316.","journal-title":"Calcif Tissue Int"},{"issue":"14","key":"1001_CR86","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/hmg\/ddr172","volume":"20","author":"A Daroszewska","year":"2011","unstructured":"Daroszewska A, van\u2019t Hof RJ, Rojas JA, Layfield R, Landao-Basonga E, Rose L, et al. A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget\u2019s disease-like disorder in mice. Hum Mol Genet. 2011;20(14):2734\u201344.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"1001_CR87","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1086\/340731","volume":"70","author":"N Laurin","year":"2002","unstructured":"Laurin N, Brown JP, Morissette J, Raymond V. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1\/p62) in Paget disease of bone. Am J Hum Genet. 2002;70(6):1582\u20138.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"1001_CR88","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/ng.562","volume":"42","author":"OM Albagha","year":"2010","unstructured":"Albagha OM, Visconti MR, Alonso N, Langston AL, Cundy T, Dargie R, et al. Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget\u2019s disease of bone. Nat Genet. 2010;42(6):520\u20134.","journal-title":"Nat Genet"},{"issue":"6","key":"1001_CR89","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.celrep.2015.09.071","volume":"13","author":"R Obaid","year":"2015","unstructured":"Obaid R, Wani SE, Azfer A, Hurd T, Jones R, Cohen P, et al. Optineurin negatively regulates osteoclast differentiation by modulating NF-kappaB and interferon signaling: implications for Paget\u2019s disease. Cell Rep. 2015;13(6):1096\u2013102.","journal-title":"Cell Rep"},{"issue":"16","key":"1001_CR90","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.cub.2007.07.041","volume":"17","author":"G Zhu","year":"2007","unstructured":"Zhu G, Wu CJ, Zhao Y, Ashwell JD. Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP. Curr Biol. 2007;17(16):1438\u201343.","journal-title":"Curr Biol"},{"issue":"1","key":"1001_CR91","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bbadis.2017.10.008","volume":"1864","author":"IAL Silva","year":"2018","unstructured":"Silva IAL, Conceicao N, Gagnon E, Caiado H, Brown JP, Gianfrancesco F, et al. Effect of genetic variants of OPTN in the pathophysiology of Paget\u2019s disease of bone. Biochim Biophys Acta Mol basis Dis. 2018;1864(1):143\u201351.","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"8","key":"1001_CR92","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1359\/jbmr.2003.18.8.1381","volume":"18","author":"K Nakatsuka","year":"2003","unstructured":"Nakatsuka K, Nishizawa Y, Ralston SH. Phenotypic characterization of early onset Paget\u2019s disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. J Bone Miner Res. 2003;18(8):1381\u20135.","journal-title":"J Bone Miner Res"},{"key":"1001_CR93","doi-asserted-by":"publisher","first-page":"115224","DOI":"10.1016\/j.bone.2020.115224","volume":"133","author":"SJ Iwamoto","year":"2020","unstructured":"Iwamoto SJ, Rothman MS, Duan S, Baker JC, Mumm S, Whyte MP. Early-onset Paget\u2019s disease of bone in a Mexican family caused by a novel tandem duplication (77dup27) in TNFRSF11A that encodes RANK. Bone. 2020;133:115224.","journal-title":"Bone."},{"issue":"1","key":"1001_CR94","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/71667","volume":"24","author":"AE Hughes","year":"2000","unstructured":"Hughes AE, Ralston SH, Marken J, Bell C, MacPherson H, Wallace RG, et al. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet. 2000;24(1):45\u20138.","journal-title":"Nat Genet"},{"issue":"3","key":"1001_CR95","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJMoa013096","volume":"347","author":"MP Whyte","year":"2002","unstructured":"Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH, et al. Osteoprotegerin deficiency and juvenile Paget\u2019s disease. N Engl J Med. 2002;347(3):175\u201384.","journal-title":"N Engl J Med"},{"issue":"9","key":"1001_CR96","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1359\/JBMR.040602","volume":"19","author":"A Daroszewska","year":"2004","unstructured":"Daroszewska A, Hocking LJ, McGuigan FE, Langdahl B, Stone MD, Cundy T, et al. Susceptibility to Paget\u2019s disease of bone is influenced by a common polymorphic variant of osteoprotegerin. J Bone Miner Res. 2004;19(9):1506\u201311.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1001_CR97","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1042\/CS20050053","volume":"109","author":"A Daroszewska","year":"2005","unstructured":"Daroszewska A, Ralston SH. Genetics of Paget\u2019s disease of bone. Clin Sci (Lond). 2005;109(3):257\u201363.","journal-title":"Clin Sci (Lond)"},{"key":"1001_CR98","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/bonekey.2015.125","volume":"4","author":"OM Albagha","year":"2015","unstructured":"Albagha OM. Genetics of Paget\u2019s disease of bone. Bonekey Rep. 2015;4:756.","journal-title":"Bonekey Rep"},{"issue":"2","key":"1001_CR99","doi-asserted-by":"publisher","first-page":"85","DOI":"10.11005\/jbm.2014.21.2.85","volume":"21","author":"DL Galson","year":"2014","unstructured":"Galson DL, Roodman GD. Pathobiology of Paget\u2019s Disease of Bone. J Bone Metab. 2014;21(2):85\u201398.","journal-title":"J Bone Metab"},{"issue":"10","key":"1001_CR100","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1210\/me.2009-0066","volume":"23","author":"E Chamoux","year":"2009","unstructured":"Chamoux E, Couture J, Bisson M, Morissette J, Brown JP, Roux S. The p62 P392L mutation linked to Paget\u2019s disease induces activation of human osteoclasts. Mol Endocrinol. 2009;23(10):1668\u201380.","journal-title":"Mol Endocrinol"},{"issue":"1","key":"1001_CR101","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1172\/JCI115584","volume":"89","author":"GD Roodman","year":"1992","unstructured":"Roodman GD, Kurihara N, Ohsaki Y, Kukita A, Hosking D, Demulder A, et al. Interleukin 6. A potential autocrine\/paracrine factor in Paget\u2019s disease of bone. J Clin Invest. 1992;89(1):46\u201352.","journal-title":"J Clin Invest"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-021-01001-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-021-01001-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-021-01001-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T17:24:19Z","timestamp":1724693059000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-021-01001-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,25]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1001"],"URL":"https:\/\/doi.org\/10.1007\/s11882-021-01001-2","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,25]]},"assertion":[{"value":"23 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"23"}}